|PROSITE documentation PDOC51749 [for PROSITE entry PS51749]|
The CRISPR (clustered regularly interspaced short palindromic repeat)-Cas (CRISPR associated) system is a naturally occuring, adaptative microbial immune system for defense against invading phages and other mobile genetic elements. Type II CRISPR-Cas systems use an RNA-guided DNA endonuclease, Cas9, to generate double strand breaks in invasive DNA during an adaptative bacterial immune response. Cas9 proteins are abundant across the bacterial kingdom, but vary widely in both sequence and size. All known Cas9 enzymes contain an HNH domain that cleaves the DNA strand complementary to the guide RNA sequence (target strand), and a RuvC nuclease domain required for cleaving the noncomplementary strand (non-target strand), yielding double strand DNA breaks (DSBs) [1,2].
The profile we developed covers the entire Cas9-type HNH domain.Last update:
March 2015 / First entry.
PROSITE method (with tools and information) covered by this documentation:
|1||Authors||Jinek M., Jiang F., Taylor D.W., Sternberg S.H., Kaya E., Ma E., Anders C., Hauer M., Zhou K., Lin S., Kaplan M., Iavarone A.T., Charpentier E., Nogales E., Doudna J.A.|
|Title||Structures of Cas9 endonucleases reveal RNA-mediated conformational activation.|
|2||Authors||Nishimasu H., Ran F.A., Hsu P.D., Konermann S., Shehata S.I., Dohmae N., Ishitani R., Zhang F., Nureki O.|
|Title||Crystal structure of Cas9 in complex with guide RNA and target DNA.|